PRTA
NASDAQ · Biotechnology
Prothena Corp Plc
$7.97
+0.08 (+1.01%)
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+69.6% upside
Low Target
$9.22
Average Target
$13.52
High Target
$14.31
Current Price
$7.97
Current
$7.97
$7.97
Target
$13.52
$13.52
$9.22
$13.52 avg
$14.31
Scenario Analysis
Bear Case
$9.22
15.7%
Low target
Base Case
$13.52
+69.6%
Avg target
Bull Case
$14.31
+79.5%
High target
Risk/Reward
5.1x
Highly favorable
Price in Context
52-Week High
$11.80
-32.5% from high
52-Week Low
$7.73
+3.1% from low
Target vs 52W High
$13.52
+14.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -41.2% |
| REGN | Buy | 36 | 72% | $76.80 | -91.5% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.7% |